Zimmer Biomet Holdings Stock Buy Hold or Sell Recommendation
ZBH Stock | USD 131.98 0.63 0.48% |
Considering the 90-day investment horizon and your slightly conservative level of risk, our recommendation regarding Zimmer Biomet Holdings is 'Hold'. Macroaxis provides Zimmer Biomet buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ZBH positions. The advice algorithm takes into account all of Zimmer Biomet's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Zimmer Biomet's buy or sell advice are summarized below:
Real Value 110.86 | Target Price 143.78 | Hype Value 131.98 | Market Value 131.98 | Naive Value 133.1 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Zimmer Biomet Holdings given historical horizon and risk tolerance towards Zimmer Biomet. When Macroaxis issues a 'buy' or 'sell' recommendation for Zimmer Biomet Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Zimmer |
Execute Zimmer Biomet Buy or Sell Advice
The Zimmer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Zimmer Biomet Holdings. Macroaxis does not own or have any residual interests in Zimmer Biomet Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Zimmer Biomet's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Zimmer Biomet Trading Alerts and Improvement Suggestions
Over 91.0% of the company outstanding shares are owned by institutional investors | |
On 31st of January 2024 Zimmer Biomet paid $ 0.24 per share dividend to its current shareholders | |
Latest headline from zacks.com: Heres Why You Should Buy Zimmer Biomet Stock Now |
Zimmer Biomet Returns Distribution Density
The distribution of Zimmer Biomet's historical returns is an attempt to chart the uncertainty of Zimmer Biomet's future price movements. The chart of the probability distribution of Zimmer Biomet daily returns describes the distribution of returns around its average expected value. We use Zimmer Biomet Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Zimmer Biomet returns is essential to provide solid investment advice for Zimmer Biomet.
Mean Return | 0.15 | Value At Risk | -1.77 | Potential Upside | 2.48 | Standard Deviation | 1.19 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Zimmer Biomet historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Zimmer Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zimmer Biomet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zimmer Biomet Holdings backward and forwards among themselves. Zimmer Biomet's institutional investor refers to the entity that pools money to purchase Zimmer Biomet's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Victory Capital Management Inc. | 2023-12-31 | 3.2 M | Van Eck Associates Corporation | 2023-12-31 | 2.8 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.8 M | Allspring Global Investments Holdings, Llc | 2023-12-31 | 2.8 M | Boston Partners Global Investors, Inc | 2023-12-31 | 2.6 M | Northern Trust Corp | 2023-12-31 | 2.5 M | Norges Bank | 2023-12-31 | 2.2 M | Neuberger Berman Group Llc | 2023-12-31 | 2.2 M | Legal & General Group Plc | 2023-12-31 | 2.1 M | Vanguard Group Inc | 2023-12-31 | 23.9 M | Blackrock Inc | 2023-12-31 | 18.7 M |
Zimmer Biomet Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Free Cash Flow | 1.2B | 1.1B | 1.3B | 1.1B | 892.4M | 899.3M | |
Depreciation | 1.0B | 1.0B | 937.7M | 926.4M | 951.7M | 514.0M | |
Capital Expenditures | 404.7M | 117.9M | 152M | 187.9M | 689.2M | 723.7M | |
Net Income | 1.1B | (137.4M) | 445.5M | 291.2M | 1.0B | 585.0M | |
End Period Cash Flow | 617.9M | 802.1M | 478.5M | 375.7M | 415.8M | 596.1M | |
Other Non Cash Items | 608.8M | 633M | 276.3M | 337.9M | (1.4M) | (1.3M) | |
Change To Inventory | (125.2M) | (40.8M) | (8.4M) | (75.6M) | (240.4M) | (228.4M) | |
Change In Cash | 75.1M | 184.2M | (323.6M) | (102.8M) | 40.1M | 42.1M | |
Change To Netincome | (384.3M) | 736.7M | 267.2M | 378.5M | 435.3M | 457.0M | |
Dividends Paid | 196.7M | 198.5M | 200.1M | 201.2M | (200.9M) | (190.9M) | |
Investments | 48.1M | 53.5M | (503.6M) | (529.2M) | (670.6M) | (637.1M) | |
Change Receivables | (93.8M) | (70M) | (15.1M) | (184.7M) | (166.2M) | (157.9M) | |
Net Borrowings | (716.1M) | (275.2M) | (1.1B) | (1.1B) | (956.1M) | (908.3M) |
Zimmer Biomet Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Zimmer Biomet or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Zimmer Biomet's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Zimmer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.04 | |
β | Beta against NYSE Composite | 0.83 | |
σ | Overall volatility | 1.23 | |
Ir | Information ratio | 0.01 |
Zimmer Biomet Volatility Alert
Zimmer Biomet Holdings has low volatility with Treynor Ratio of 0.17, Maximum Drawdown of 6.17 and kurtosis of 1.87. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Zimmer Biomet's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Zimmer Biomet's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Zimmer Biomet Fundamentals Vs Peers
Comparing Zimmer Biomet's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Zimmer Biomet's direct or indirect competition across all of the common fundamentals between Zimmer Biomet and the related equities. This way, we can detect undervalued stocks with similar characteristics as Zimmer Biomet or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Zimmer Biomet's fundamental indicators could also be used in its relative valuation, which is a method of valuing Zimmer Biomet by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Zimmer Biomet to competition |
Fundamentals | Zimmer Biomet | Peer Average |
Return On Equity | 0.0836 | -0.31 |
Return On Asset | 0.044 | -0.14 |
Profit Margin | 0.14 % | (1.27) % |
Operating Margin | 0.24 % | (5.51) % |
Current Valuation | 32.69 B | 16.62 B |
Shares Outstanding | 205.08 M | 571.82 M |
Shares Owned By Insiders | 0.12 % | 10.09 % |
Shares Owned By Institutions | 91.10 % | 39.21 % |
Number Of Shares Shorted | 4.59 M | 4.71 M |
Price To Earning | 77.41 X | 28.72 X |
Price To Book | 2.18 X | 9.51 X |
Price To Sales | 3.66 X | 11.42 X |
Revenue | 7.39 B | 9.43 B |
Gross Profit | 4.92 B | 27.38 B |
EBITDA | 2.34 B | 3.9 B |
Net Income | 1.02 B | 570.98 M |
Cash And Equivalents | 375.7 M | 2.7 B |
Cash Per Share | 2.71 X | 5.01 X |
Total Debt | 6 B | 5.32 B |
Debt To Equity | 0.48 % | 48.70 % |
Current Ratio | 1.98 X | 2.16 X |
Book Value Per Share | 60.70 X | 1.93 K |
Cash Flow From Operations | 1.58 B | 971.22 M |
Short Ratio | 3.30 X | 4.00 X |
Earnings Per Share | 4.88 X | 3.12 X |
Price To Earnings To Growth | 2.56 X | 4.89 X |
Target Price | 136.61 | |
Number Of Employees | 18 K | 18.84 K |
Beta | 1.01 | -0.15 |
Market Capitalization | 27.07 B | 19.03 B |
Total Asset | 21.5 B | 29.47 B |
Retained Earnings | 10.38 B | 9.33 B |
Working Capital | 1.75 B | 1.48 B |
Note: Disposition of tradable shares by Lori Winkler of Zimmer Biomet at 124.28 subject to Rule 16b-3 [view details]
Zimmer Biomet Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Zimmer . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 22987.94 | |||
Daily Balance Of Power | (0.27) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 132.75 | |||
Day Typical Price | 132.49 | |||
Price Action Indicator | (1.09) | |||
Period Momentum Indicator | (0.63) |
About Zimmer Biomet Buy or Sell Advice
When is the right time to buy or sell Zimmer Biomet Holdings? Buying financial instruments such as Zimmer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 511M | 985M | 1.3B | 941.7M | Total Assets | 23.5B | 21.1B | 21.5B | 13.7B |
Use Investing Ideas to Build Portfolios
In addition to having Zimmer Biomet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
View All Next | Launch |
Check out Zimmer Biomet Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.96 | Earnings Share 4.88 | Revenue Per Share 35.43 | Quarterly Revenue Growth 0.063 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.